Changes of Content of Matrix Metalloproteinases and Their Tissue Expression in Various Types of Atherosclerotic Plaques

Aim: to investigate diagnostically significant for atherosclerotic plaques (ASP) of various types parameters of activity of matrix metalloproteinases (MMP-3, MMP-7, MMP-9) in homogenates, as well as tissue expression of MMP-2, MMP-9 and collagen type IV. Materials and methods. We included in this study 54 men with coronary atherosclerosis without acute coro nary syndrome who underwent coronary artery bypass surgery with endarterectomy. In the obtained samples we determined levels of MMP-3, MMP-7, and MMP-9 (by enzyme immunoassay), as well as tissue expression of antibodies to MMP-2, MMP-9 and collagen type IV. Results. In unstable plaques we observed increased activity of MMP-7 and MMP-9, significant increase of tissue expression of MMP-2 and MMP-9, and decreased expression of type IV collagen. Of three types of unstable ASP the highest tissue expression of MMP-9 was found in plaques of lipid type compared with plaques of necrotic and inflammatory-erosive types. Expression of type IV collagen predominated in plaques of necrotic type. Conclusion. The data obtained allows us to speak about tissue expression of collagen as the marker of fibrous cap stability; the presence of metalloproteinases in necrotic detritus, collagen fibers, and cellular elements can characterize an ASP as unstable or being in the transitional structural state. The immunohistochemical method helps to detect structural elements that characterize instability in various types of ASP.

атеросклеротические бляшки, атеросклероз, иммуногистохимия, металлопротеиназы, коллаген, atherosclerotic plaques, atherosclerosis, immunohistochemistry, metalloproteinases, collagen

1. Baber U., МеЬгап R., Sartori S. et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults. The Bioimage Study. J. Am Coll Cardiol 2015;65 (n):1065-1074.

2. Савченко С. В. Патоморфологические исследования в судебно-медицинской практике на современном этапе. Вестник судебной медицины 2015;4 (2);21-24

3. Савченко С. В., Новоселов В. П., Морозова А. С. и др. Оценка выраженности экспрессии коннексина 43 в миокарде при острой ишемии в эксперименте. Патология кровообращения и кардиохирургия 2017;1:81-90). DOI: 10.21688-1681-3472-2017-1-81-90.

4. Рагино Ю. И., Чернявский А. М., Волков А. М. и др. Факторы и механизмы развития коронарного атеросклероза. Новосибирск: Наука; 2011. 168 с

5. Wasserman E.J., Shippley N. М. Atherothrombosis in acute coronary syndromes: mechanisms, markers, and mediators, of vulnerability. Mount Sinai J. Med 2006;73 (1):431-440.

6. Шлычкова Т. П., Жданов В. С., Карпов Ю. А. Чумаченко П. В. Основные типы нестабильных атеросклеротических бляшек и их распространенность в коронарных артериях при остром инфаркте миокарда. Арх патол 2005;3:24-28

7. Zorina S. Galis, Jaikirshan J. Khatri. Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis. The Good, the Bad, and the Ugly. Circ Res 2002;90:251-262. DOI: 10.1161/hh0302.105345

8. Pasterkamp G., Schoneveld A. H., Hijnen D.J. et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000;150:245-253. DOI: 10.1016/S0021-9150 (99) 00371-8

9. Pyo R., Lee J. K., Shipley J. M. et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin Invest 2000;105:1641-1649. DOI: 10.1172/JCI8931

10. Мурашов И. С., Савченко С. В., Волков А. М., и др. Основные механизмы развития атеросклероза. Вестник судебной медицины 2017;6 (1):31-36

11. Wang X., Connolly T. М. Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. Adv Clin Chem 2010;50:1-22. DOI: 10.1016/S0065-2423 (10) 50001-5

12. Алекперов Э. З., Наджафов Р. Н. Современные концепции о роли воспаления при атеросклерозе. Кардиология 2010;6:88-91

13. Newby A. C. Dual role of matrix metalloproteinases in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005;85:1-31. DOI:10.1152/physrev. 00048.2003

14. Рагино Ю. И., Чернявский А. М., Полонская Я. В. и др. Изменение содержания провоспалительных цитокинов и матриксных металлопротеиназ в процессе развития атеросклеротического очага до нестабильной бляшки. Кардиология 2009;6:43-49

15. Ambrose J. A., Srikanth S. Vulnerable plaques and patients: improving prediction of future coronary events. Am J. Med 2010;123:10-16. DOI: 10.1016/j.amjmed. 2009.07.019

16. Shah P. K., Sharifi B. Insights into the Molecular Mechanisms of Plaque Rupture and Thrombosis. Biochemistry of Atherosclerosis, edited by S. K. Cheema, Springer, New York, 2006;455-563. DOI: 10.1007/0-387-36279-3_21

17. Pyo R. T., Sato Y., Mackman N., Taubman M. B. Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration. Thromb Haemost 2004;92 (3):451-458. DOI: 10.1160/TH04-02-0122

18. Raggi P. Coronary atherosclerosis: an intra or extra luminal disease? Atherosclerosis 2015;243:344-345. DOI: 10.1016/j.athero-sclerosis. 2015.09.007

19. Subbotin V. M. Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target. Drug Discov Today 2016;21 (10):1578-1595. DOI: 10.1016/j.drudis. 2016.05.017